FIT Screening - UK - Norfolk & Norwich University Hospital Trust: FIT Pilot Study

The World’s No. 1 Faecal Immunochemical Test

Skip navigation
  • Home
  • Screening
  • Symptomatic
  • Resources
  • About us
 
Skip navigation
  • Contact
 
Skip navigation
  • Downloads
  • News
    • Reflection
    • Use of faecal immunochemical testing as an alternative to faecal calprotectin in children by K.Sandhu, S.Naik and R.M.Ayling FCal and FIT in Paedeatrics. February 2021
    • New Product
    • BLOG: Bowel cancer surveillance for high-risk patients in the time of COVID-19: What have we learned?
    • Testing for colorectal cancer: A focus on FIT technology
    • NG12 – OC Sensor™ shown to be cost effective
    • Cutting edge development
    • Royal Preston Hospital Adopts the OC-Sensor™ Faecal Immunochemical Test
    • Fit Around The World
    • Getting FIT in Nottingham
    • Level 3 Liquid Control
    • Norfolk & Norwich University Hospital Trust: FIT Pilot Study
    • Luton & Dunstable Poster
    • Meet The Team
    • OC-Sensor™ At IBMS Congress 2019
    • Customer Testimonials
    • A summary of ‘Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham by C.Chapman et al., December 2019’
    • A summary of ‘Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test by Pin-Vieito et al,. January 2020’
  • Events
  • Studies OC-Sensor™
  • FAQs
  • Links
 

Doctors

Skip navigation
  • Screening With OC-Sensor™
  • OC-Sensor™ Sample Bottles
 

Laboratories

Skip navigation
  • OC-Sensor™ Pledia
  • OC-Sensor™ iO
  • OC-Sensor™ Reagents
 

Publications

About us

Skip navigation
  • About Mast Group
  • About EIKEN
  • Certified quality
  • News
  • Links
 

Mast Group Ltd . Mast House, Derby Road, Bootle, England, L20 1EA . Tel: +44 (0) 151 933 7277 fit@mastgrp.com

Skip navigation
  • Terms and Conditions
  • Privacy
 

Design & development: ideenhafen